Helicobacter pylori Infections Global Clinical Trials Review, H2, 2017

2017-09-01
Price :
Published : Sep-2017
No. of Pages : 314

Helicobacter pylori Infections Global Clinical Trials Review, H2, 2017

Summary

GlobalData’s clinical trial report, “Helicobacter pylori Infections Global Clinical Trials Review, H2, 2017” provides an overview of Helicobacter pylori Infections clinical trials scenario. This report provides top line data relating to the clinical trials on Helicobacter pylori Infections. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database – Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

– The report provides a snapshot of the global clinical trials landscape
– Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
– The Report provides enrollment trends for the past five years
– Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

– Assists in formulating key business strategies with regards to investment
– Helps in identifying prominent locations for conducting clinical trials which saves time and cost
– Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
– Supports understanding of trials count and enrollment trends by country in global therapeutics market
– Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
– Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Filed in: Pharmaceutical, Pharmaceuticals and Healthcare
Publisher : GlobalData
More Reports
Title Price Buy Now

WellSpring Pharmaceutical Corp – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary WellSpring Pharmaceutical Corp (WellSpring Pharma) is a healthcare products provider that offers medicinal products. The company develops over the counter consumer pharmaceuticals and new prescription drugs. Its products include bonine, gelusil, emetrol, bactine, micatin, glaxal base, FDS, barriere silicone skin cream, K-LYTE potassium supplement, and others. WellSpring Pharma's products are provided in the dosage forms of tablets, liquids and semi-solids. The company's services include WPC outsourcing, and patient assistance. It also provides contract manufacturing services to other pharmaceutical companies. The company operates through its manufacturing plant in Oakville, Ontario, Canada. WellSpring Pharma is headquartered in Sarasota, Florida, the US. WellSpring Pharmaceut......
$250

Presidio Pharmaceuticals Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Presidio Pharmaceuticals Inc (Presidio) is a clinical-stage pharmaceutical company that discovers and develops small-molecule antiviral therapeutics. The company's products include HCV NS5A, NS5B proteins, lead pan-genotypic HCV NS5A inhibitor, ravidasvir hydrochloride, protease inhibitor, faldaprevir and non-nucleoside inhibitor. Presidio's lead pan-genotypic HCV NS5A inhibitor, ravidasvir hydrochloride has completed phase 1 clinical studies in both healthy volunteers and HCV patients. Its second pan-genotypic HCV inhibitor PPI-383 is a NS5B non-nucleoside inhibitor currently being evaluated in phase 1 studies. The company also has an extensive intellectual property portfolio for its HCV programs. Presidio is headquartered in San Francisco, California, the US. Presidio Pharm......
$250

OneWorld Health – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary OneWorld Health (iOWH) is a healthcare service provider that discovers, develops, and delivers safe, effective, and affordable new treatments for diseases disproportionately affecting people in the world. The center treats infectious diseases such as diarrheal diseases, visceral leishmaniasis, soil-transmitted helminthiasis, malaria and chagas disease. Its products include paromomycin, synthetic artemisinin, and others. The center has collaborated with many hospitals in the US and abroad for development of new medicines, regulatory approval and manufacturing the drugs. iOWH is headquartered in Charleston, South Carolina, the US. OneWorld Health - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Merg......
$250

Medison Pharma Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Medison Pharma Ltd (Medison) is a drug company that develops and manufactures medical products. The company's oncology products include vectibix, myocet, aranesp, symphony and coloprint. Its neurology products are avonex, tysabri, fampyra, provigil, stryker, dysport and firdapse. Medison offers products in the areas of neurology, oncology, human genetics, nephrology, cardiology, hematology, aesthtics, endocrinology, infectious diseases and allergology. The company serves healthcare solution companies in Romania and Israel. It operates through its offices located in Israel and Romania. Medison is headquartered in Petach Tikva, Israel. Medison Pharma Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the compan......
$250

Tarsa Therapeutics Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Tarsa Therapeutics Inc (Tarsa) develops therapies for the treatment and prevention of osteoporosis and other bone related diseases. The company develops TBRIA, an oral formulation of calcitonin, a peptide hormone that inhibits bone resorption, which is used for the treatment of postmenopausal osteoporosis in women at least five years post menopause. The company also offers osteoporosis treatment and osteoporosis prevention clinical programs. Tarsa is headquartered in Philadelphia, Pennsylvania, the US. Tarsa Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisit......
$250

Eurofarma Laboratorios SA – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Eurofarma Laboratorios SA (Eurofarma), formerly Bill Farmaceutica is a pharmaceutical company that manufactures and markets prescription, generic and veterinary drugs. The company offers prescription products which include aerosol ointment, alprazolam, acebrophylline, altiva, ebastel, fluoruracila, gemcitabine cloridate, and others. Its veterinary products comprise anesthetic L, aminofort, bertac liquid, genesis ivor pour-on, hipotac, and others. Eurofarma offers hospital drug products such as amoxicillin, amoxicillin + clavulanate, cephtriaxone sodium, cefepime hydrochloride, omeprazole sodium and others. The company operates in Argentina, Bolivia, Chile, Colombia, Guatemala, Peru and Uruguay. Eurofarma is headquartered in Sao Paulo, Brazil. Eurofarma Laboratorios SA - Pharm......
$250

McGill University – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary McGill University (McGill) is a research based educational institute. The university offers undergraduate, graduate and post-graduate courses. It provides academic courses across various disciplines including agricultural and environmental sciences, arts, dentistry, education, engineering, law, management, medicine, music and science among others. The university carries research and licensing technologies in several domains which include agriculture, mechanical and materials, genomics and proteomics, nanotechnologies, climate research, biomedical, network communications, food technology, clean technology, therapeutic agents. McGill works in collaboration with hospitals, research institutions and health centers such as Jewish General Hospital, The Shriners Hospital, St. Mary's Ho......
$250

Anthem Inc (ANTM) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Anthem Inc (Anthem), formerly WellPoint Inc, is a health benefits company. It offers several managed healthcare related products and related administrative services. It also provides various specialty and insurance products and services including radiology benefit management, dental, life and disability insurance benefits, and analytics-driven personal health care. Anthem offers its products and services to large and small employer, federal government, Medicaid and Medicare markets, and individuals. Its various types of medical membership customers include Local Group, Individual, National Accounts, BlueCard, Medicare, Medicaid, and Federal Employee Program (FEP). The company is an independent licensee of the Blue Cross and Blue Shield Association (BCBSA), and has license for in......
$250

HCA Healthcare Inc (HCA) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary HCA Healthcare Inc (HCA), formerly known as HCA Holdings Inc, is a health care services company that provides a wide range of services in specialties including internal medicine; general surgery, cardiology, oncology, neurosurgery, orthopedics and obstetrics. It also offers outpatient and ancillary health care services; diagnostic and emergency services and mental health care services. The company operates a network of hospitals; freestanding surgery centers and emergency care facilities; diagnostic and imaging centers; radiation and oncology therapy centers; comprehensive rehabilitation and physical therapy centers; and various other facilities. HCA operates its facilities in various states of the US and in England, the UK. HCA is headquartered in Nashville, Tennessee, the US. ......
$250

ethris GmbH – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary ethris GmbH (Ethris) is a biotechnology company that develops and manufactures therapeutics. The company develops therapeutics based on its proprietary platform technologies. It uses technologies including magnetovax and SNIM RNA. Ethris' magnetovax is a platform for personalized tumor vaccines localized and activated in tumors by magnetic fields and transports nucleic acid agents. The company's drug candidates include ETH-CFTR, ETH-CCDC40, ETH-CCNO and ETH-OTC. It partners with academic and medical institutions in Germany and abroad for its research and development activities. Ethris is headquartered in Planegg, Germany. ethris GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acq......
$250